Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption

被引:0
|
作者
R. B. Elliott
D. P. Harris
J. P. Hill
N. J. Bibby
H. E. Wasmuth
机构
[1] Department of Paediatrics,
[2] School of Medicine,undefined
[3] Auckland,undefined
[4] New Zealand,undefined
[5] Food Science Section,undefined
[6] New Zealand Dairy Research Institute,undefined
[7] Palmerston North,undefined
[8] New Zealand,undefined
[9] Diabetes Research Institute,undefined
[10] University of Düsseldorf,undefined
[11] Germany,undefined
来源
Diabetologia | 1999年 / 42卷
关键词
Keywords Milk; casein; epidemiology; immunosuppression; beta-casomorphin.;
D O I
暂无
中图分类号
学科分类号
摘要
Previously published Type I (insulin-dependent) diabetes mellitus incidence in 0 to 14-year-old children from 10 countries or areas was compared with the national annual cow milk protein consumption. Countries which were selected for study had appropriate milk protein polymorphism studies, herd breed composition information and low dairy imports from other countries. Total protein consumption did not correlate with diabetes incidence (r = + 0.402), but consumption of the β-casein A1 variant did (r = + 0.726). Even more pronounced was the relation between β-casein (A1 + B) consumption and diabetes (r = + 0.982). These latter two cow caseins yield a bioactive peptide β-casomorphin-7 after in vitro digestion with intestinal enzymes whereas the common A2 variant or the corresponding human or goat caseins do not. β-casomorphin-7 has opioid properties including immunosuppression, which could account for the specificity of the relation between the consumption of some but not all β-casein variants and diabetes incidence. [Diabetologia (1999) 42: 292–296]
引用
收藏
页码:292 / 296
页数:4
相关论文
共 50 条
  • [41] INSULIN-DEPENDENT DIABETES-MELLITUS
    GINSBERGFELLNER, F
    PEDIATRIC ANNALS, 1980, 9 (04): : 24 - &
  • [42] Lipoprotein(a) in insulin-dependent diabetes mellitus
    LiszewskaPfejfer, D
    Krolak, R
    Koczaj, M
    Korczak, D
    Jasinska, A
    Wasilewski, P
    Bobilewicz, D
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 381 - 381
  • [43] Genetics of insulin-dependent diabetes mellitus
    Ikegami, H
    Ogihara, T
    ENDOCRINE JOURNAL, 1996, 43 (06) : 605 - 613
  • [44] The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus
    Fagerudd, JA
    Pettersson-Fernholm, KJ
    Grönhagen-Riska, C
    Groop, PH
    DIABETOLOGIA, 1999, 42 (05) : 519 - 526
  • [45] THE IMMUNOGENETICS OF INSULIN-DEPENDENT (TYPE-I) DIABETES
    FLETCHER, JA
    BARNETT, AH
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1989, 1 (01): : 44 - 47
  • [46] INSULIN-DEPENDENT DIABETES-MELLITUS
    RYFF, AS
    BERGER, W
    CRAUSAZ, F
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 124 (21) : 7 - 13
  • [47] INSULIN-DEPENDENT DIABETES-MELLITUS
    DONOHUEPORTER, P
    NURSING CLINICS OF NORTH AMERICA, 1985, 20 (01) : 191 - 198
  • [48] Immunogenetics of insulin-dependent diabetes mellitus
    Kida, K
    Kaino, Y
    Ito, T
    Hirai, H
    Nakamura, K
    ACTA PAEDIATRICA, 1999, 88 : 3 - 7
  • [49] Costs of insulin-dependent diabetes mellitus
    Currie, C
    Peters, J
    DIABETIC MEDICINE, 1996, 13 (07) : 684 - 684
  • [50] Immunotherapy of insulin-dependent diabetes mellitus
    Bach, JF
    CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (05) : 601 - 605